Responses
Other responses
Jump to comment:
- Published on: 23 November 2015
- Published on: 23 November 2015
- Published on: 23 November 2015Low-intensity vitamin K antagonists in preference to aspirin for low risk patients with NVAFShow More
Dear Editor,
Given the fact that abnormalities of coagulation rather than platelet abnormalities are the one which predominate in atrial fibrillation (AF)(1)(2), it seems more plausible to rely on low-intensity anticoagulation along the lines of BAATAF(3) and SPINAF(4) rather than on aspirin(1) when managing patients with non valvar atrial fibrillation (NVAF) deemed to be at low risk of thromboembolism. The princ...
Conflict of Interest:
None declared. - Published on: 23 November 2015Antithrombotic treatment in atrial fibrillationShow More
Dear Editor,
Given the fact that BAATAF conferred a relative risk reduction of 86%, and SPINAF conferred a relative risk reduction of 79% for embolic complications of non valvular atrial fibrillation(NVAF) utilising INR ranges of 1.5-2.7, and 1.4-2.8, respectively(1)(2), in a population presumably comprising, not only NVAF patients at high risk of embolic complications, but also those at low risk, the hypothesis...
Conflict of Interest:
None declared.